Avoro Capital Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History

Avoro Capital Advisors’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,273	Closed	-$700K	–	48
2018 Q3	$700K	Sell	2,273 -15,944	-88%	-$4.9M	0.03%	42
2018 Q2	$5.53M	Hold	18,217	–	–	0.21%	37
2018 Q1	$7.53M	Buy	+18,217	New	+$7.47M	0.36%	33

Other funds holding ONCS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Avoro Capital Advisors's ONCS Position: Q4 2018 in Review

Avoro Capital Advisors sold out of OncoSec Medical Incorporated (ONCS) in Q4 2018, closing a stake of 2,273 shares — an estimated $700K sold.

Avoro Capital Advisors first reported a position in ONCS in Q1 2018 and held it in 3 quarters. The position peaked at $7.53M in Q1 2018. 33 funds tracked by Wall St. Rank hold ONCS as of Q4 2018.

Avoro Capital Advisors reported no remaining OncoSec Medical Incorporated position as of Q4 2018 after selling out during the quarter.
Avoro Capital Advisors sold 2,273 OncoSec Medical Incorporated shares in Q4 2018, an estimated $700K.
Avoro Capital Advisors first reported a position in OncoSec Medical Incorporated in Q1 2018 and held it in 3 quarters.
Avoro Capital Advisors's OncoSec Medical Incorporated position peaked at $7.53M in Q1 2018.
33 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2018.

Based on Avoro Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.